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ABSTRACT 
This study aimed to characterize the cases of tuberculosis (TB) co-infected with the 
human immunodeficiency virus (HIV) in Minas Gerais State, Brazil, after the notification 
sheet modification, and to verify the association between the new variables and the treatment 
outcome. It is an analytical cross-sectional study with TB/HIV cases notified in the year 
2016 to the Brazilian Information System for Notifiable Diseases (Sistema de Informação de 
Agravos de Notificação). Descriptive statistics, chi-square test, and multiple correspondence 
analysis were performed to verify the association between the outcome, ageand associated 
diseases. Of the 180 cases, most were male (75.6%) between 30 and 49 years old (63.3%), 
mixed ethnicity (black and white) (49.4%), 94.4% had the Acquired Immunodeficiency 
Syndrome (AIDS) and 60.6% had pulmonary TB. The molecular test was not performed at 
the time of diagnosis in 70.5% of the cases. Homeless people (4.4%) and prisoners (3.9%) 
featured prominently among the special populations. People between 40 and 49 years old 
without concurrent diseases were cured in 40.0% of the cases; 18.9% abandoned the treatment 
due to smoking, drug abuse and mental illness in the age group between 20 and 29 years 
old. The deaths were associated with the age group between 30 and 39 years old and the 
occurrence of AIDS. The results have shown that the groups considered vulnerable (drug users, 
smokers and people with mental illness) abandoned the treatment, the notification upon death 
from AIDS in adults was late and some treatments were inadequate. The epidemiological 
surveillance, prevention and assistance strategies towards cases of TB/HIV must be improved 
in order to achieve the goal of the Brazilian National Plan to end Tuberculosis as a Public 
Health Problem until 2035 in the state.
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INTRODUCTION 
Tuberculosis (TB) is the 9th cause of death around the world. In 2016, 1.3 million 
deaths from TB were estimated among HIV-negative people and 374,000 deaths 
were estimated among HIV-positive people. Of the total cases of TB/HIV, 85% were 
on antiretroviral therapy (ART), and the successful rate of treatment was 78%1. The 
specific goals to eradicate TB until 2030 include 90% reduction in deaths and 80% 
reduction of TB incidence per year1. One of the factors hindering the elimination 
of TB is the emergence of HIV/Aids epidemics, since HIV-positive individuals are 
more likely to have the disease throughout their lives2-4. 
HIV has a huge impact on perpetuation of TB, increasing the incidence and 
mortality rates of the disease5. Other conditions and diseases that also interfere 
with the immunological state enabling the emergence of latent TB, such as alcohol 
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consumption, illicit drugs, smoking and the presence of 
chronic diseases, like diabetes6. These chronic factors may 
interfere with the outcomes of TB/HIV coinfection (cure, 
deaths, and abandonment of treatment)7. It is recommended 
that every patient with TB should be tested for HIV, but, 
in many regions, the frequency of notified cases of TB that 
were positive for HIV is low1,2,8,9.
In Brazil, at the end of 2014, there was a change in 
TB notification and the compulsory notification became 
mandatory in the HIV-positive cases. The new notification 
encompassed the identification of associated factors 
that may favor the emergence of the disease and cause 
complications, the identification of populations vulnerable 
to the infection, the result of the rapid molecular test and the 
use of ART. Given the introduction of a new TB notification, 
it was necessary to assess the association of treatment 
outcomes after the inclusion of these new variables. The 
purpose of this work is to characterize the cases of TB 
coinfected with HIV and to verify the combination of the 
new variables with the closure status of the cases.
MATERIALS AND METHODS
This was an analytical cross-sectional study with 
reported cases of TB coinfected with HIV in Minas 
Gerais State, Brazil, in 2016, registered in the Brazilian 
Information System for Notifiable Diseases (SINAN), 
provided by the State Office of Health of Minas Gerais 
(SES/MG – Secretaria do Estado da Saúde de Minas 
Gerais). Minas Gerais State has 853 cities with 21,119,536 
inhabitants (in 2017), and is considered the second most 
populated state in Brazil.
Due to the period of implantation and adaptation to the 
new TB notification in the state, 2016 was the year chosen 
because it contains cases after this phase and the cases 
had a concluded closure status with respect to treatment, 
considering that TB is treated for at least 6 months.
Variables selected for this study were: cases of 
TB/HIV, closure status (cure, abandonment, death from 
TB, death from other causes), age group, sex, ethnicity, 
education, district, pregnant woman, type of entrance, 
special populations (prisoners, healthcare practitioners, 
immigrants, homeless people), type of disease (pulmonary, 
extra-pulmonary or pulmonary and extra-pulmonary), 
associated diseases and disorders (AIDS, alcoholism, 
diabetes, smoking, mental illness, illicit drug abuse), sputum 
smear microscopy, chest X-ray, ART use and HIV test, as 
well as the rapid molecular test. Blank data or data specified 
as a not specified category was considered unknown10. 
The inclusion criteria were new cases notified in 2016 
with closure status defined as cured, abandoned, death from 
TB and death from other causes. Blank outcomes (without 
a defined closure status) were excluded. 
Data were analyzed with the Statistica software version 
10 (StatSoft, USA), through descriptive statistics, and 
the differences between proportions of the variables and 
the closure status of the case were verified through the 
Chi-square test. The variables with significant difference 
(p≤0.05) were included in the Multiple Correspondence 
Analysis (MCA), enabling to verify the association between 
the “additional” variable closure status of the case with the 
other “active” variables in a factorial plan11-13. 
The project was approved by the Human Research 
Ethics Committee of the Federal University of Triangulo 
Mineiro (UFTM – Universidade Federal do Triângulo 
Mineiro), opinion Nº 2.099.176. The Free and Informed 
Consent was not used as we dealt with secondary data from 
a database and had no variables identifying the participants.
RESULTS
In 2016, 466 cases of TB/HIV coinfection were notified 
in Minas Gerais State. Of these, 180 met the inclusion 
criteria. Of the cases analyzed, 75.6% were male, most 
of them in the age groups between 30 and 39 years old 
(36.7%) and between 40 and 49 years old (25.6%), were 
mixed ethnicity (black and white) (49.4%) or white (27.5%), 
living in the urban area (97.0%) (Table 1). Cases of pregnant 
women were not registered in this year and there was a high 
rate of unknown education (53.9%); 40.0% of the cases 
were cured, 18.9% abandoned treatment and 33.9% passed 
away for causes other than TB.
The predominant clinical form was pulmonary (60.6%), 
followed by extra-pulmonary (28.9%). The predominant 
diagnostic method was the chest X-ray (73.6%) of the cases. 
The rapid molecular test and the sensitivity test had not 
yet been implemented in Minas Gerais State, and were not 
performed in 70.5% and 57.1% of the cases, respectively 
(Table 2). 
Among the cases, 94.4% had AIDS with an associated 
disease, and only 57.4% were on ART, 30.7% were 
alcoholic, 23.5% used illicit drugs and 26.8% were smokers 
(Table 3). Among the special populations, homeless people 
(4.5%), prisoners (3.9%) and beneficiaries of government 
programs (3.9%) featured prominently. Cases in healthcare 
practitioners were not registered. 
The multiple correspondence analysis considered the 
new cases of TB coinfected with HIV/AIDS where the 
outcome variable was the closure status regarding the cure, 
abandonment and deaths from TB and other causes. It was 
verified that the deaths from TB were associated with the 
age group between 50 and 59 years old, whereas the deaths 
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from other causes were mainly associated with AIDS, lack 
of information regarding other associated diseases and age 
between 30 and 39 years old. People cured were associated 
with absence of diseases and were in the age group between 
40 and 49 years old, meanwhile, the cases of abandonment 
of treatment were associated with the age group between 
20 and 29 years old and with illicit drug use, smoking, and 
mental illness, as well as diseases associated with TB/HIV 
coinfection. HIV infection without AIDS was associated 
with patients under the age of 19 years old (Figure 1).
DISCUSSION
Many factors increase the susceptibility to infection by 
Mycobacterium tuberculosis, such as impairment of the 
immune system by several diseases and medicines, like 
HIV and AIDS, type II diabetes, terminal kidney disease, 
alcoholism, intravenous drug abuse, certain types of cancer, 
chemotherapy to treat cancer, malnutrition and very young 
or advanced age. Some other factors include the use of 
tobacco, which increases the risk of contracting and dying 
due to TB14,15.
The insertion of the variable “diseases and disorders 
associated” to TB, included in the notification, was 
correlated with the treatment outcomes, being a favorable 
indication of its importance to assess and supervise the 
cases of TB/HIV. The insertion of the variable “special 
populations” showed low number of cases in which 
Table 1 - Distribution of the sociodemographic profile of TB/HIV coinfection cases, Minas Gerais State, Brazil, 2016.
Variables Healing N (%)
Abandonment 
N (%)
Death TB 
N (%)
Death other 
causes 
N (%)
Total 
N (%) p
Gender  0.35
Male 57(31.7) 22(12.2) 11 (6.1) 46 (25.6) 136 (75.6)
Female 15 (8.3) 12 (6.7) 2 (1.1) 15 (8.3) 44 (24.4)
Age group  0.01
0 to 9 years old 1 (0.6) 1 (0.6) 0 (0.0) 1 (0.6) 3 (1.7)
From 10 to 19 years old 1 (0.6) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.6)
From 20 to 29 years old 11 (6.1) 6 (3.3) 0 (0.0) 11 (6.4) 28 (15.6)
From 30 to 39 years old 21(11.0) 19(10.6) 5 (2.8) 21 (11,7) 66 (36.7)
From 40 to 49 years old 23(12.8) 7 (3.9) 2 (1.1) 14 (7.8) 46 (25.6)
From 50 to 59 years old 13 (7.2) 1 (0.6) 2 (1.1) 11 (6.1) 27 (15.0)
≥ 60 years old 2 (1.1) 0 (0.0) 4 (2.2) 3 (1.7) 9 (5.0)
Education 0.11
1st to 4thgrades aC and I 11 (6.1) 4 (2.2) 3 (1.7) 8 (4.4) 26 (14.4)
5th to 8thgrades aC and I 18(10.0) 4 (2.2) 4 (2.2) 8 (4.4) 34 (18.9)
High school aC and I 5 (2.8) 7 (3.9) 0 (0.0) 1 (0.6) 13 (7.2)
Higher education aC and I 4 (2.2) 0 (0.0) 0 (0.0) 2 (1.1) 6 (3.3)
Illiterate 1 (0.6) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.6)
Not applicable 1 (0.6) 1 (0.6) 0 (0.0) 1 (0.6) 3 (1.7)
Ignored 32(17.8)  18(10.0) 6 (3.3) 41 (22.8) 97 (53.9)
Ethnicity 0.73
Mixed (Black and White) 32(18.0)  22(12.4) 6 (3.4) 28 (15.80) 88 (49.4)
White 22(12.4) 6 (3.4) 3 (1.7) 18 (10.1) 49 (27.5)
Black 12 (6.7) 4 (2.3) 4 (2.3) 9 (5.0) 29 (16.3)
Ignored 6 (2.3) 2 (1.1) 0 (0.0) 5 (2.8) 13 (6.2)
Asian 1 (0.6) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.6)
Zone 0.65
Urban 68(39.5) 28(16.3) 11 (6.4) 60 (34.9) 167 (97.0)
Rural 2 (1.2) 1 (0.6) 1 (0.6) 1 (0.6) 5 (2.9)
aC and I = complete and incomplete. Data source: Notification of Injury Information System from the Minas Gerais State.
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information was provided and they were not associated 
with the outcome in the MCA12,13.
An association between treatment abandonment and 
diseases associated with smoking, illicit drug use and 
mental illness was observed. The ratio of people abandoning 
the treatment was 18.9%, higher than the ratio verified in 
Alagoas State (10.42%) and Piaui State (4.8%)2. 
Tobacco smoking interferes by suppressing the 
activation of the immune response inherent to bacterial 
infections. Nicotine may inhibit the signaling of T cells and 
production of antibodies, in addition to a potential inhibition 
of apoptosis, a defense mechanism against TB infection15,16. 
Studies indicate that alcohol and drug consumption favor 
abandonment of treatment, as well as poverty and low 
education7. The improper alcohol consumption also impairs 
the immune system, inhibiting cellular functioning and 
hindering the destruction of invasive microorganisms. It 
also interferes with the production of signaling molecules 
that directly help the immune response, such as cytokines, 
increasing the susceptibility to TB15. In a literature review 
study, Cruz et al.17 reported that the illicit drug abuse 
favors the dissemination of TB. Crack (cocaine) induces 
cough, favors intimate contact in closed environments 
and intermittent people flow. In addition, there was 
spread of HIV infection among malnourished drug users 
as malnutrition makes the users even more vulnerable. 
Table 2 - Distribution of TB/HIV coinfection cases, according to the results of molecular tests and the sensitivity test, smear 
microscopy after 6 months of treatment, chest X-Ray and clinical form, Minas Gerais State, Brazil, 2016.
Variables Cure N (%)
Abandonment 
N (%)
Death TB 
N (%)
Death other 
causes 
N (%)
Total 
N (%) p
Rapid Molecular test for TB  0.09
Not performed 48 (27.3) 21 (12.0) 9 (5.1) 46 (26.1) 124 (70.45)
Detectable sensitive to rifampicin 13 (7.4) 6 (3.4) 1 (0.6) 6 (3.4) 26 (14.8)
Not detectable 8 (4.6) 6 (3.4) 0 (0.0) 6 (3.4)  20 (11.3)
Detectable rifampicin resistant 1 (0.6) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.6)
Inconclusive 0 (0.0) 0 (0.0) 2 (1.1) 3 (1.7) 5 (2.8)
Sensitivity Testa 0.55
Not performed 8 (22.9) 5 (14.3) 1 (2.9) 6 (17.2) 20 (57.1)
In progress 1 (2.9) 0 (0.0) 0 (0.0) 0 (0.0) 1 (2.9)
Sensitive 8 (22.9) 0 (0.0) 0 (0.0) 2 (5.7) 10 (28.6)
Resistant to other first line drugs 0 (0.0) 1 (2.9) 0 (0.0) 0 (0.0) 1 (2.9)
Resistant to isoniazid 1 (2.9) 1 (2.9) 0 (0.0) 1 (2.9) 3 (8.6)
Smear microscopy after 6 months 0.47
Not applicable 27 (35.6) 10 (13.2) 2 (2.6) 20 (26.3) 59 (77.6)
Not performed 5 (6.6) 1 (1.3) 1 (1.3) 3 (4.0) 10 (13.2)
Negative 6 (7.9) 0 (0.0) 0 (0.0) 0 (0.0) 6 (7.9)
Positive 1 (1.3) 0 (0.0) 0 (0.0) 0 (0.0) 1 (1.3)
Chest X-Ray  0.21
Suspect 52 (29.2) 28 (15.7) 9 (5.0) 42 (23,6) 131 (73.6)
Normal 11 (6.2) 4 (2.2) 0 (0.0) 10 (5.6) 25 (14.0)
Not performed 6 (3.4) 2 (1.1) 4 (2.2) 5 (2.8) 17 (9.5)
Other pathology 2 (1.1) 0 (0.0) 0 (0.0) 3 (1.7)  5(2.8)
Clinical form 0.32
Pulmonary 37 (20.6) 24 (13.3)  10 (5.6) 38 (21.1) 109 (60.6)
Extra-pulmonary 24 (13.3) 7 (93.9) 2 (1.1) 19 (10.6) 52 (28.9)
Pulmonary and extra-pulmonary 11 (6.1) 3 (1.7) 1 (0.6) 4 (2.2) 19 (10.6)
aOnly 35 responded. Data source: Notification of Injury Information System from the Minas Gerais State.
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Another literature review study indicates that the illicit drug 
abuse favors the low adherence to and the abandonment 
of treatment. The stereotypes associated with drug abuse 
poses an obstacle in the appropriate approach to users, and 
the healthcare practitioners do not have a specific ability 
to make this approach18. 
Other factors may also contribute to the non-adherence 
to treatment, such as the use of other medicines, the type 
of medicine, history of previous treatment of TB and 
previous abandonment, the lack of training of healthcare 
practitioners, low doctor-patient interaction, need to 
hospitalization, operational problems to follow the 
treatment, fear to be stigmatized and discriminated after 
the disclosure of the HIV diagnosis, side effects and drugs 
Table 3 - Distribution of TB/HIV coinfection cases, according to types of associated aggravations and use of antiretroviral therapy, 
Minas Gerais State, Brazil, 2016.
Associated aggravations Cure N (%)
Abandonment 
N (%)
Death TB 
N (%)
Death other causes 
N (%)
Total 
N (%) p
Aids  0.01
Yes 67 (37.2) 32 (17.8) 10 (5.6) 61 (33.9) 170 (94.4)
No 5 (2.8) 1 (0.6) 3 (1.7) 0 (0.0) 9 (5.0)
Ignored 0 (0.0) 1 (0.6) 0 (0.0) 0 (0.0) 1 (0.6) 
Alcohol 0.15
Yes 17 (9.5) 12 (6.7) 5 (2.8) 21 (11.7) 55 (30.7)
No 49 (27.3) 19 (10.6) 6 (3.5) 27 (15.1) 101 (56.4)
Ignored 6 (3.3) 3 (1.7) 2 (1.1) 12 (6.7) 23 (12.8)
Diabetes 0.07
Yes 1 (0.6) 1 (0.6) 0 (0.0) 1 (0.6) 3 (1.7)
No 68 (38.0) 31 (17.3) 9 (5.0) 54 (30.2) 162 (90.5)
Ignored 3 (1.7) 2 (1.1) 4 (2.2) 5 (2.8) 14 (7.8)
Mental illness 0.04
Yes 0 (0.0) 2 (1.1) 0 (0.0) 1 (0.6) 3 (1.7)
No 70 (39.1) 30 (16.8) 10 (5.6) 55 (30.8) 165 (92.2)
Ignored 2 (1.1) 2 (1.1) 3 (1.7) 5 (2.4) 12 (6.1)
Other 0.46
Yes 3 (2.0) 1 (0.7) 2 (1.3) 5 (3.3) 11 (7.3)
No 49 (32.7) 23 (15.3) 7 (4.7) 42 (28.0) 121 (80.7)
Ignored 7 (4.7) 2 (1.3) 3 (2.0) 6 (4.0) 18 (12.0)
Use of illicit drugs 0.00
Yes 9 (5.0) 18 (10.1) 1 (0.6) 14 (7.8) 42 (23.5)
No 53 (29.6) 11 (6.1) 9 (5.0) 31 (17.3) 104 (58.1)
Ignored 10 (5.6) 5 (2.8) 3 (1.7) 15 (8.4) 33 (18.4)
Tobacco smoking 0.00
Yes 18 (10.1) 13 (7.3) 3 (1.7) 14 (7.8) 48 (26.8)
No 50 (27.9) 18 (10.1) 4 (2.2) 36 (20.1) 108 (60.3)
Ignored 4 (2.2) 3 (1.7) 6 (3.3) 10 (5.6) 23 (12.9)
Use of antiretroviral therapy 0.03
Yes 38 (27.9) 13 (9.6) 6 (4.4) 21 (15.4) 78 (57.4)
No 9 (6.6) 10 (7.4) 3 (2.2) 21 (15.4) 43 (31.6)
Ignored 7 (5.1) 2 (1.5) 3 (2.2) 3 (2.2) 15 (11.0)
Data source: Notification of Injury Information System from the Minas Gerais State.
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toxicity, the patient’s disbelief in the treatment efficacy, 
complexity of treatment, different place to treat TB and 
HIV/AIDS, difficulty to give the TB diagnosis to patients 
with AIDS, depression and no social support18. 
It is known that the pulmonary TB is relevant to the 
public health due to its high infectivity and the easy 
diagnosis in comparison to other types of TB, helping to 
interrupt the chain of transmission2,19. Pulmonary TB was 
predominant (60.6%), followed by extrapulmonary TB 
(28.9%). A similar result of 62.7% was observed in a study 
carried out in the city of Contagem, Minas Gerais State20. In 
a national-based study, a similar result was also observed, 
between 37% and 40% for extrapulmonary TB, and 59% 
and 62% for pulmonary TB21. The results are also similar 
to the ones found in Ethiopia, where 51.8% of the patients 
had pulmonary TB and 44% had extrapulmonary TB22.
In 2014, the Rapid Molecular Test Network (RTR-TB – 
Rede de Teste Rápido Molecular) was implemented in the 
public health system in order to diagnose TB and there was 
progress during the first years of RTR-TB use. The test is 
important to reduce the spread of the disease, since it detects 
the presence or absence of the bacillus, quickly shows the 
resistance to rifampicin, facilitating the work process of 
healthcare teams and the epidemiological surveillance, 
speeding up the beginning of treatment, whether TB is 
resistant or not to the drugs23. In Minas Gerais State, 
many individuals were not submitted to the molecular test 
(70.45%) and to the drug-sensitivity test (57.1%), being 
an indication that RTR-TB has not shown epidemiological 
impacts in Minas Gerais State so far according to the 
results,probably due to the fact that Minas Gerais was the 
15th state to perform the test and one of the states with higher 
rates of underused equipments23-25. 
Most cases of TB/HIV were in male adults (75.6%), 
with acquired immunodeficiency syndrome (AIDS) and 
pulmonary TB. Belo et al.26 found a significant difference 
between sex and delay in the diagnosis of the disease, 
being higher in women than in men (p<0.05), which can be 
explained by the differences in behavior between genders, 
being reported that men had early and rapid access to quality 
health services. The high proportion of cases in males with 
working age between 30 and 49 years old (63.3%), being 
most of mixed ethnicity (black and white) (49.4%), was 
also observed in other researches using SINAN in different 
states of Brazil2,21. Magno et al.21 verified predominance in 
males (>71%), in the age group between 25 and 40 years 
old (>53%), in mixed ethnicity (black and white) patients 
(>83%). A study carried out in Piaui State between 2007 and 
2016 with cases of TB/HIV coinfection has also observed 
predominance in males (75.4%), in the age group between 
20 and 49 years old (79.5%) and in mixed ethnicity (black 
and white) patients (73.8%)2. 
Considering that almost every patient had AIDS and that 
a little more than half of them used ART (57.4%), which 
is important for the the immune system function, the low 
percentage of cure (40%) and the significant number of 
patients abandoning treatment may be related to the low 
adherence to ART and to diseases and disorders associated 
Figure 1 - Factors associated with the closure of the TB/HIV coinfection cases, Minas Gerais State, Brazil, 2016.
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with TB. All cases were of TB coinfected with HIV and, 
therefore, they should be on medication recommended to all 
HIV-positive patients regardless of their CD4 count and the 
virus count, according to a 2013 recommendation24, and that 
the treatment of the TB/HIV coinfection follows the same 
principles that the one in non-HIV infected individuals27. 
ART reduces the risk of TB among people living with 
HIV/AIDS in 67% and, if expanded, may contribute to 
reduce TB rates at the population level28-30. 
TB/HIV coinfection may favor resistance to drugs, 
attributed to the immunological state and potential 
abandonments prior to treatment. The proportion of TB 
multi-resistant to other first-class drugs was 2.9%, a rate 
higher than the one verified in a study by Gaspar et at.31 
who reported it in 0.17% in patients coinfected with 
TB/HIV and in a study by Silva et al.32 in 0.14%, in TB 
cases without HIV coinfection. 
The TB cure rate of 40.0% was lower than the rate 
verified by Oliveira et al.2 in Piaui State (60.8%), by Silva 
et al.32 in Alagoas State (57.03%), and in Brazil between 
2002-2012 (50.74%)31. The low cure rate must be analyzed 
with special attention by health authorities, as cure benefits 
not only the patient, but the entire social scope in which 
the patient is inserted, breaking the chain of transmission32, 
particularly in smear-positive pulmonary cases, the majority 
group in this study (60.6%).
It was verified that the cure was associated with 
individuals between 40 and 49 years old, without diseases 
related to TB, probably because this group is composed by 
people who are more careful with their health since they 
do not use drugs, tobacco, and they do not drink alcoholic 
beverages in an abusive way and are possibly favored as 
they do not have diabetes, mental illness and other diseases 
concurrent to HIV/AIDS. A study carried out by Gaspar 
et al.31 has shown that patients with TB/HIV have 48% 
less chance to be cured, 50% are more likely to stop the 
treatment and 94% are more likely to die from TB with 
respect to those without coinfection.
The deaths from other causes, excepting for TB, were 
associated with the ages between 30 and 39 years old, having 
AIDS and other diseases associated with TB registered as 
unknown, probably because the notification was made at 
the time of the death, explaining why the practitioner who 
made the notification failed to collect the information from 
the patient itself or from their family members. Deaths from 
TB totaled 7.2% of the notifications and deaths from other 
causes totaled 33.9%. A study carried out in Amazonas State 
with cases of TB/HIV reported that deaths took place in the 
age group between 25 and 39 years old and were more likely 
to be notified, increasing the chance of TB notification by 
40%21. In Piaui State, the death rate was lower than the one 
in this study (3.5%), and the same happened in a research 
carried out with national data (3.63%) for patients with TB/
HIV31 coinfection, and deaths from other causes have also 
shown a lower rate (3.8%)2. 
Prisoners totaled 3.9% of the cases. A study carried 
out in Alagoas State reported that people confined in 
overcrowded and unhealthy environments with inadequate 
ventilation had a higher exposure to risk factors related to 
the infection by Mycobacterium tuberculosis, but they found 
a lower proportion of cases (2.84%)32. 
On the other hand, homeless people in this study were 
4.4%, a fact that concerns the sanitary authorities, since 
they perpetuate the disease, particularly with respect 
to the optimization of treatment strategies in this target 
audience. Purely biomedical approaches have a limited 
effect on the cure, since they do not consider important 
factors predisposing to the disease33,34. Interventions 
should go beyond approaches to individual lifestyle factors, 
considering health inequalities that lead to exclusion, 
malnutrition, poor access to diagnostic services and health 
care, in addition to improper use of legal substances 
such as alcohol and tobacco, and illicit substances, like 
crack (cocaine). A study evaluated the experience of 
healthcare practitioners in the care of homeless people 
with TB, concluding that a complete human resource staff 
is not enough to provide health care for this population, 
as the adherence to treatment is complex. Factors such 
as intersectionality and availability of resources and 
government incentives are important, such as public 
transportation vouchers, basic food basket and the directly 
observed treatment35. 
There was no registration of cases in healthcare 
practitioners. Despite being a risk group for this infection 
due to exposure to patients during the workday and 
shortage of administrative, environmental control, and 
individual protection measures36. Even in the absence of 
cases, it is necessary to be alert to the early diagnosis in 
this target audience, since the study carried out in the city 
of Vitoria, Espirito Santo State, with primary care health 
practitioners found a high prevalence of latent infection 
by Mycobacterium tuberculosis in this population, ranging 
from 39.4% to 54.1%, with a higher proportion among the 
community health workers37.
As one of the main challenges of the Brazilian National 
Plan for the End of Tuberculosis as a Public Health Problem, 
it is important to improve the diagnostic network for TB and 
resistant TB; expand and maintain the RTR-TB; implement 
surveillance of TB deaths, latent infection and resistant 
TB; improve information systems for monitoring and 
decision-making purposes; strengthen the disease control 
actions in the most vulnerable populations; approach the 
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disease in the perspective of social determinants; expand 
the decentralization and qualification of coping actions in 
basic care and improve the treatment outcome indicators24. 
The limitations of the study include the use of secondary 
data sources with predetermined variables, with possible 
lack of information and underreporting of cases. However, 
since TB is a disease whose treatment is offered only in the 
public health network, the underreporting of this disease 
is likely to be reduced. A recent study in Amazonas State 
has indicated an underreporting rate of HIV cases of 7.7%, 
while the national average was 6.9%21. 
People with communicable chronic diseases such as 
TB and HIV/AIDS are more likely to develop chronic non-
communicable diseases, and if they coexist with TB/HIV, 
they increase the risk or the effect of the other. Generally, 
resource-constrained healthcare services are unprepared to 
deal with the dual burden of the disease, and the care and 
specific approaches to the disease are not the most efficient 
response to treat the coinfection. Traditional approaches 
need to be reevaluated, with greater emphasis on the 
multidisciplinary approach with the assistance of integrated 
care management33,38-40.
CONCLUSION
The results indicate that abandonment of treatment 
should be reduced in vulnerable groups, late notification 
of TB only at death should be avoided, the proportion of 
treatment effectiveness should be increased, the molecular 
and sensitivity tests and adherence to the use of ART 
should be expanded. The inclusion of diseases associated 
with TB in the new notification form was correlated with 
treatment outcome, being an indicative of its relevance for 
the follow-up of new cases. Strategies for controlling the 
double burden of diseases (TB/HIV) should be reissued 
in the state in order to reach the goals of the Brazilian 
National Plan for the End of Tuberculosis as a Public 
Health Problem until 2035. There are points of weakness 
in the epidemiological surveillance in Minas Gerais State 
to comply with the protocol recommended for cases of TB 
with HIV coinfection.
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